Skip to main content

Beam Therapeutics Inc.

BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001745999

In the last 90 days, Beam Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 277 institutions reported holding it in 13F filings for Q2 2026, worth $3.75B in total; superinvestors ARK Invest and Duquesne Family Office hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Beam Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
2 insiders, $2.19M in total
Insiders trading
2
Net value
−$2.19M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Beam Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Beam Therapeutics Inc.
NameTitleLast reported holdingLast filingFilings, past year
Ciaramella GiuseppePresident130,504Sep 25, 20266
Simon AmyChief Medical Officer85,696Jul 29, 20266
Evans John M.CEO1,047,205Jul 1, 20265
FMR LLC10% Owner, Other: See Remark 1854,583IndirectJun 29, 20263
Maraganore JohnDirector–Jun 5, 20261
Cooper Graham KDirector0Jun 5, 20261
Walsh Kathleen EDirector–Jun 5, 20261
Shaw ChristiDirector–Jun 5, 20261
Guindo ChirfiDirector–Jun 5, 20261
Fishman MarkDirector–Jun 5, 20261
Bellon ChristineChief Legal Officer109,711Apr 6, 20267
Cavanagh Bethany JSVP, Finance and Treasurer51,171Apr 6, 20266
Emany Sravan KumarChief Financial Officer105,456Apr 2, 20263
Ho CaroleDirector–Jun 6, 20250
Burrell Terry-AnnChief Financial Officer82,637Apr 29, 20240
Burow KristinaDirector12,067Jun 8, 20230
Crandell Keith10% Owner28,111Jul 2, 20210
Nelsen Robert10% Owner28,111Jul 2, 20210
Bybee Clinton10% Owner28,111Jul 2, 20210
ARCH Venture Fund IX, L.P.10% Owner28,111Jul 2, 20210
ARCH Venture Fund IX Overage, L.P.10% Owner28,111Jul 2, 20210
ARCH Venture Partners IX Overage, L.P.10% Owner28,111Jul 2, 20210
ARCH Venture Partners IX, L.P.10% Owner28,111Jul 2, 20210
ARCH Venture Partners IX, LLC10% Owner28,111Jul 2, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 29, 2026 (view filing)4:05 PM ETJul 272 daysSimon AmyChief Medical OfficerSSale−16.7K$25.74−$429.0K−16.3%85.7K after10b5-1
Jul 2, 2026 (view filing)4:05 PM ETJun 302 daysSimon AmyChief Medical OfficerSSale−373$34.73−$13.0K−0.4%102.4K after10b5-1
Jul 1, 2026 (view filing)4:05 PM ETJun 29-302 daysEvans John M.CEOSSale−50.0K$34.90−$1.75M−4.6%1.05M after4 lots10b5-1
Jun 29, 2026 (view filing)Jun 25-264 daysFMR LLC10% Owner, Other: See Remark 1SSale−284.9K$35.24−$10.0M−25.0%854.6K after2 lots
Apr 6, 2026 (view filing)Apr 15 daysLateEvans John M.CEOSSale−30.1K$24.58−$739.3K−2.8%1.05M after10b5-1
Apr 6, 2026 (view filing)Apr 15 daysLateSimon AmyChief Medical OfficerSSale−6.70K$24.58−$164.7K−6.1%102.7K after10b5-1
Apr 6, 2026 (view filing)Apr 15 daysLateCavanagh Bethany JSVP, Finance and TreasurerSSale−3.24K$24.58−$79.7K−6.0%51.2K after10b5-1
Apr 6, 2026 (view filing)Apr 15 daysLateBellon ChristineChief Legal OfficerSSale−5.96K$24.58−$146.4K−5.1%109.7K after10b5-1
Apr 6, 2026 (view filing)Apr 15 daysLateCiaramella GiuseppePresidentSSale−11.8K$24.58−$290.3K−5.1%218.4K after10b5-1
Apr 1, 2026 (view filing)Mar 30-312 daysEvans John M.CEOSSale−50.0K$22.57−$1.13M−4.8%986.7K after2 lots10b5-1
Feb 26, 2026 (view filing)Feb 242 daysCiaramella GiuseppePresidentSSale−35.0K$32.00−$1.12M−15.5%190.2K after10b5-1
Feb 2, 2026 (view filing)Jan 29-304 daysEvans John M.CEOSSale−50.0K$28.87−$1.44M−4.8%986.7K after4 lots10b5-1
Jan 26, 2026 (view filing)Jan 224 daysCavanagh Bethany JSVP, Finance and TreasurerSSale−6.20K$35.00−$216.9K−15.1%34.8K after10b5-1
Jan 26, 2026 (view filing)Jan 224 daysBellon ChristineChief Legal OfficerSSale−1.37K$34.00−$46.6K−1.4%95.7K after10b5-1
Jan 21, 2026 (view filing)Jan 201 dayCavanagh Bethany JSVP, Finance and TreasurerSSale−3.03K$30.12−$91.4K−6.9%41.0K after10b5-1
Jan 20, 2026 (view filing)Jan 155 daysBellon ChristineChief Legal OfficerSSale−18.6K$34.62−$644.9K−16.1%97.0K after3 lots10b5-1
Jan 5, 2026 (view filing)Dec 31, 20255 daysEmany Sravan KumarChief Financial OfficerSSale−6.29K$27.10−$170.6K−7.9%73.7K after10b5-1
Jan 5, 2026 (view filing)Dec 31, 20255 daysBellon ChristineChief Legal OfficerSSale−1.25K$27.10−$34.0K−1.1%115.7K after10b5-1
Oct 29, 2025 (view filing)Oct 272 daysFMR LLC10% Owner, Other: See Remark 1SSale−459$26.68−$12.2K−97.0%14 after
Oct 3, 2025 (view filing)Oct 12 daysCavanagh Bethany JSVP, Finance and TreasurerSSale−467$24.53−$11.5K−1.0%44.0K after10b5-1
Oct 3, 2025 (view filing)Oct 12 daysBellon ChristineChief Legal OfficerSSale−373$24.53−$9.15K−0.3%116.9K after10b5-1
Oct 3, 2025 (view filing)Oct 1-22 daysEvans John M.CEOSSale−50.0K$24.57−$1.23M−4.8%986.7K after2 lots10b5-1
Aug 1, 2025 (view filing)Jul 302 daysFMR LLC10% Owner, Other: See Remark 1SSale−48.4K$20.50−$991.7K−2.3%2.07M after
Jul 3, 2025 (view filing)Jul 1-32 daysSimon AmyChief Medical OfficerSSale−1.25K$19.17−$24.0K−1.9%64.9K after2 lots10b5-1
Apr 3, 2025 (view filing)Apr 12 daysBellon ChristineChief Legal OfficerSSale−5.67K$18.35−$104.1K−4.6%117.3K after10b5-1
Apr 3, 2025 (view filing)Apr 12 daysEvans John M.CEOSSale−30.7K$18.35−$562.7K−3.0%986.2K after10b5-1
Apr 3, 2025 (view filing)Apr 12 daysCiaramella GiuseppePresidentSSale−7.43K$18.35−$136.4K−3.8%190.2K after10b5-1
Apr 3, 2025 (view filing)Apr 12 daysCavanagh Bethany JSVP, Finance and TreasurerSSale−3.02K$18.35−$55.3K−6.3%44.5K after10b5-1
Apr 3, 2025 (view filing)Apr 1-22 daysSimon AmyChief Medical OfficerSSale−30.6K$17.92−$547.8K−31.7%65.7K after2 lots10b5-1
Feb 20, 2025 (view filing)Feb 182 daysCavanagh Bethany JSVP, Finance and TreasurerSSale−6.29K$35.00−$220.0K−14.3%37.5K after10b5-1
Feb 19, 2025 (view filing)Feb 145 daysBellon ChristineChief Legal OfficerSSale−10.0K$34.00−$340.0K−8.9%103.0K after10b5-1
Feb 3, 2025 (view filing)Jan 304 daysEvans John M.CEOSSale−30.0K$26.75−$802.6K−3.2%908.7K afterFrom original2 lots10b5-1
Jan 6, 2025 (view filing)Jan 24 daysBellon ChristineChief Legal OfficerSSale−1.24K$24.68−$30.6K−1.2%103.0K after10b5-1
Jan 6, 2025 (view filing)Jan 24 daysCavanagh Bethany JSVP, Finance and TreasurerSSale−1.12K$24.68−$27.6K−2.5%43.8K after10b5-1
Nov 8, 2024 (view filing)Nov 62 daysCiaramella GiuseppePresidentSSale−51.1K$26.36−$1.35M−31.9%109.2K after10b5-1
Oct 16, 2024 (view filing)Oct 142 daysCiaramella GiuseppePresidentSSale−51.1K$26.27−$1.34M−24.2%160.3K after10b5-1
Oct 2, 2024 (view filing)Oct 11 dayBellon ChristineChief Legal OfficerSSale−385$23.48−$9.04K−0.4%104.2K after10b5-1
Oct 2, 2024 (view filing)Oct 11 dayCavanagh Bethany JSVP, Finance and TreasurerSSale−289$23.48−$6.79K−0.6%44.9K after10b5-1
Oct 2, 2024 (view filing)Sep 302 daysEvans John M.CEOSSale−60.0K$24.60−$1.48M−6.0%938.7K after10b5-1
Jul 3, 2024 (view filing)Jul 1-22 daysSimon AmyChief Medical OfficerSSale−1.25K$23.28−$29.1K−1.8%68.8K after2 lots10b5-1
Jun 28, 2024 (view filing)Jun 271 dayEvans John M.CEOSSale−60.0K$24.50−$1.47M−5.7%998.3K after10b5-1
Apr 3, 2024 (view filing)Apr 1-22 daysSimon AmyChief Medical OfficerSSale−23.7K$31.02−$734.8K−25.3%70.1K after2 lots10b5-1
Apr 3, 2024 (view filing)Apr 12 daysBellon ChristineChief Legal OfficerSSale−3.40K$32.12−$109.2K−3.1%104.6K after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysBurrell Terry-AnnChief Financial OfficerSSale−5.45K$32.12−$174.9K−7.2%70.1K after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysEvans John M.CEOSSale−18.1K$32.13−$581.6K−1.7%1.06M after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysCiaramella GiuseppePresidentSSale−4.53K$32.12−$145.6K−2.6%169.6K after10b5-1
Apr 1, 2024 (view filing)Mar 284 daysEvans John M.CEOSSale−60.0K$33.86−$2.03M−5.7%998.3K after10b5-1
Feb 15, 2024 (view filing)Feb 13-142 daysFMR LLCOther: See Remark 1SSale−901.6K$30.55−$27.5M−42.2%1.24M after4 lots
Feb 2, 2024 (view filing)Jan 312 daysEvans John M.CEOSSale−60.0K$25.33−$1.52M−5.4%1.06M after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysBellon ChristineChief Legal OfficerSSale−1.91K$26.42−$50.4K−2.3%80.5K after10b5-1